首页> 外国专利> ENHANCEMENT OF ORAL BIOAVAILABILITY OF NON-EMULSIFIED FORMULATION OF CEFDITOREN PIVOXIL WITH LECITHIN

ENHANCEMENT OF ORAL BIOAVAILABILITY OF NON-EMULSIFIED FORMULATION OF CEFDITOREN PIVOXIL WITH LECITHIN

机译:卵磷脂与头孢呋辛酯联用未乳化制剂的口服生物利用度的提高

摘要

A method for enhancing the oral bioavailability of a prodrug ester by formulating the ester as non-emulsified formulation with lecithin; as well as a pharmaceutical composition of at least one antibiotic and lecithin in a non-emulsified formulation; a method of treating infections with the non-emulsified formulation, and a method for preparing tablets by direct compression of blends of drugs with lecithin are disclosed. Non-emulsified formulations include solids, tablets, capsules, lozenges, suspensions, elixirs and solutions, and exclude emulsions, liposomes, lipid matrix systems and micro-emulsions. A suitable prodrug ester is a cephalosporin ss-lactam antibiotic such as cefditoren pivoxil, and a suitable non-emulsified formulation is a solid formulation.
机译:一种通过将卵磷脂配制为非乳化制剂来增强前药酯的口服生物利用度的方法;以及非乳化制剂中的至少一种抗生素和卵磷脂的药物组合物;公开了一种用非乳化制剂治疗感染的方法,以及通过直接压制药物与卵磷脂的混合物制备片剂的方法。非乳化制剂包括固体,片剂,胶囊剂,锭剂,混悬剂,e剂和溶液,并且不包括乳剂,脂质体,脂质基质系统和微乳剂。合适的前药酯是头孢菌素β-内酰胺抗生素,例如头孢托仑匹罗西尔,合适的非乳化制剂是固体制剂。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号